News

India on track to have regulatory framework around OTC drugs soon
India may soon have a streamlined regulatory framework around over-the-counter (OTC) drugs as the apex advisory board of ...
The Business Times10m
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, ...
ZAWYA18m
US pharma tariffs would raise US drug costs by $51bln annually, report finds
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...
KCUR40m
Trump's tariffs won't get him what he wants, Missouri supply chain expert says
Haitao Li, chair of the supply chain analytics department at the University of Missouri-St. Louis, says that the Trump ...
US pharma tariffs would raise US drug costs by $51 billion annually, report finds
A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a ...